移植患者的治疗策略。
Therapeutic strategy in the transplanted patient.
机构信息
Juan González del Castillo, Emergency Department. Hospital Clínico San Carlos, Calle Professor Martín-Lagos s/n, 28040 Madrid.
出版信息
Rev Esp Quimioter. 2023 Nov;36 Suppl 1(Suppl 1):18-21. doi: 10.37201/req/s01.05.2023. Epub 2023 Nov 24.
Abstract
The SARS-CoV-2 infection prognosis has dramatically changed as a result of population vaccination and the surge of omicron. However, there are still specific populations at risk of progression to severe diseases that require hospitalization or even at risk of death. The kidney transplant population is one of them. Consequently, when compatible symptoms appear, an early diagnosis should be sought in order to start specific antiviral treatment as soon as possible to avoid clinical deterioration of the patient. Antivirals have shown, in transplant patients, a decrease in the rate of hospitalization and death, especially with their early administration.
摘要
由于人群接种疫苗和奥密克戎的出现，SARS-CoV-2 感染的预后发生了巨大变化。然而，仍有特定人群有进展为需要住院治疗甚至有死亡风险的严重疾病的风险。肾移植受者就是其中之一。因此，当出现相容症状时，应尽早寻求诊断，以便尽快开始进行特定的抗病毒治疗，以避免患者的临床恶化。抗病毒药物已在移植患者中显示出降低住院率和死亡率的效果，尤其是早期使用时。
相似文献
1
Therapeutic strategy in the transplanted patient.移植患者的治疗策略。
Rev Esp Quimioter. 2023 Nov;36 Suppl 1(Suppl 1):18-21. doi: 10.37201/req/s01.05.2023. Epub 2023 Nov 24.
2
Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients.第三剂 SARS-CoV-2 疫苗接种后低抗刺突抗体水平与肾移植受者因有症状突破感染而住院之间的关联。
Ann Lab Med. 2024 Jan 1;44(1):64-73. doi: 10.3343/alm.2024.44.1.64. Epub 2023 Sep 4.
3
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.通过 SARS-CoV-2 变异株时代的肾移植受者中 COVID-19 的结局：抗 SARS-CoV-2 单克隆抗体的作用。
Transpl Int. 2022 Oct 4;35:10721. doi: 10.3389/ti.2022.10721. eCollection 2022.
4
Outcomes and Effects of Vaccination on Sars-Cov-2 Omicron Infection in Kidney Transplant Recipients.接种疫苗对肾移植受者感染 SARS-CoV-2 奥密克戎的结果和影响。
Transplant Proc. 2023 May;55(4):820-823. doi: 10.1016/j.transproceed.2023.04.016. Epub 2023 Apr 17.
5
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.奥密克戎变异株的流行和抗 SARS-CoV-2 疫苗接种是系统性自身免疫性风湿病患者 COVID-19 轻症化的关键决定因素。
Clin Rheumatol. 2023 Dec;42(12):3375-3385. doi: 10.1007/s10067-023-06769-4. Epub 2023 Sep 21.
6
COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes.肾移植和肾胰联合移植受者队列中感染奥密克戎SARS-CoV-2变异株的COVID-19：临床特征、危险因素和结局
Transplantation. 2022 Sep 1;106(9):1860-1866. doi: 10.1097/TP.0000000000004203. Epub 2022 Aug 19.
7
Mortality Due to COVID-19 in Renal Transplant Recipients, Related to Variants of SARS-CoV-2 and Vaccination in Mexico.墨西哥与 SARS-CoV-2 变异株和疫苗接种相关的肾移植受者 COVID-19 死亡率。
Transplant Proc. 2022 Jul-Aug;54(6):1434-1438. doi: 10.1016/j.transproceed.2022.05.010. Epub 2022 Jun 1.
8
Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge.门诊管理疑似 COVID-19 的肾移植受者-纽约市疫情期间的单中心经验。
Transpl Infect Dis. 2020 Dec;22(6):e13383. doi: 10.1111/tid.13383. Epub 2020 Jul 6.
9
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性：一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
10
The Antiviral Effect of Nirmatrelvir/Ritonavir during COVID-19 Pandemic Real-World Data.奈玛特韦/利托那韦在 COVID-19 大流行真实世界数据中的抗病毒效果。
Viruses. 2023 Apr 16;15(4):976. doi: 10.3390/v15040976.
引用本文的文献
1
COVID-19 in Lung Transplant Recipients: A Report on 10 Recent Cases.肺移植受者中的 COVID-19：10 例近期病例报告。
Viruses. 2024 Apr 29;16(5):709. doi: 10.3390/v16050709.
本文引用的文献
1
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice.瑞德西韦降低了 COVID-19 变异波期间住院免疫功能低下患者的死亡率：来自常规临床实践的发现。
Clin Infect Dis. 2023 Dec 15;77(12):1626-1634. doi: 10.1093/cid/ciad460.
2
Impact of the COVID-19 pandemic on demand for emergency department care for older patients: the EDEN-7 COVID cohort study.COVID-19 大流行对老年患者急诊需求的影响：EDEN-7 COVID 队列研究。
Emergencias. 2023 Aug;35(4):270-278. doi: 10.55633/s3me/E042.2023.
3
Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.瑞士社区获得性 SARS-CoV-2 奥密克戎变异株感染与流感感染的住院结局比较。
JAMA Netw Open. 2023 Feb 1;6(2):e2255599. doi: 10.1001/jamanetworkopen.2022.55599.
4
Population-based evaluation of the effectiveness of nirmatrelvir-ritonavir for reducing hospital admissions and mortality from COVID-19.基于人群的评价显示，奈玛特韦-利托那韦可降低 COVID-19 住院率和死亡率。
CMAJ. 2023 Feb 13;195(6):E220-E226. doi: 10.1503/cmaj.221608.
5
Mortality risk model validation in a prospective cohort of patients from the sixth wave of the COVID-19 pandemic in a hospital emergency department.在一家医院急诊科第六波 COVID-19 大流行的前瞻性队列中验证死亡率风险模型。
Emergencias. 2023 Feb;35(1):15-24. doi: 10.55633/s3me/E094.2023.
6
Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）核酸检测呈阳性的供体器官移植：器官获取与移植网络特设疾病传播咨询委员会的报告
Transpl Infect Dis. 2023 Feb;25(1):e14013. doi: 10.1111/tid.14013. Epub 2023 Jan 24.
7
Transplantation of organs from SARS-CoV-2-positive donors: Preliminary experience from Spain.来自新冠病毒阳性供体的器官移植：西班牙的初步经验。
Transpl Infect Dis. 2023 Feb;25(1):e14008. doi: 10.1111/tid.14008. Epub 2023 Jan 19.
8
Sociodemographic characteristics, comorbidity, and baseline functional status of older patients treated in emergency departments during the COVID-19 pandemic and associations with mortality: an analysis based on the EDENCOVID cohort.在 COVID-19 大流行期间，在急诊科接受治疗的老年患者的社会人口统计学特征、合并症和基线功能状况及其与死亡率的关系：基于 EDENCOVID 队列的分析。
Emergencias. 2022 Dec;34(6):428-436.
9
Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series.尼马瑞韦/利托那韦联合他克莫司用于肺移植受者：一项单中心病例系列研究。
Transplantation. 2023 May 1;107(5):1200-1205. doi: 10.1097/TP.0000000000004394. Epub 2022 Oct 28.
10
Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 - United States, April-September 2022.帕克洛维德降低 COVID-19 成年患者住院率-美国，2022 年 4 月-9 月。
MMWR Morb Mortal Wkly Rep. 2022 Dec 2;71(48):1531-1537. doi: 10.15585/mmwr.mm7148e2.
Zotero 插件